reason report
price chang estim chang analysi
increas price model continu
reiter invest rate increas former
price target per share follow
compani better consensu expect subsequ
guidanc rais importantli busi model continu
inflect favor organ growth approach still
realiz oper leverag throughout urolift adopt
build momentum manta begin contribut ez-plaz
still horizon remain optimist regard compani
prospect opinion remain growth margin
expans stori valuat may begin also reflect larger
address financi latitud pursu accret acquisit
longer term accordingli reiter invest rate
revis price target share
increas price increas former
price target per share revis
price target assum revenu ebitda non-
earn multipl approxim
chang estim fine-tun former
billion revenu non-gaap earn estim
billion per share respect similarli
revis former billion revenu non-
earn estim billion per share
note modest reduct former non-gaap earn
estim stem primarili increas sg estim
compani continu support global commerci urolift
earn estim revis summar tabl
left
rel valuat summari share current valu
revenu ebitda
peer trade like multipl respect
teleflex inc headquart wayn pa
lead global medic technolog hospit suppli
compani manufactur market clinic
differenti dispos product design use
oper critic care set addit
act oem supplier
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
guidanc updat increas compani previous announc revenu guidanc rang
billion billion revis rang billion billion pre-call consensu billion specif
take mid-point compani constant currenc revenu guidanc growth attribut
urolift compani forecast growth balanc busi
addit compani maintain adjust gross margin guidanc moder adjust
oper margin guidanc former rang revis rang result
higher fx headwind per share versu per share increas sell expens drive revenu
specif urolift invest upgrad compani qualiti system protect ip portfolio
result compani continu forecast non-gaap earn rang per share pre-cal
summari review tfx total revenu million pre-cal consensu million increas
report constant currenc basi versu prior year period quarterli gross margin increas
year-over-year result increas sale volum on-going cost improv program favor
product mix partial off-set fx headwind tariff higher logist distribut cost inflat tfx adjust
oper margin decreas year year result fx heighten sell expens invest
compani qualiti system protect ip portfolio off-set note improv gross margin
result report non-gaap earn growth per share
sale primari busi segment global vascular access revenu million increas
term constant currenc report global intervent revenu million increas
constant currenc basi report global surgic realiz revenu million increas
constant currenc basi report global anesthesia revenu million decreas
constant currenc basi report global intervent urolog increas constant currenc
basi report million revenu increas constant currenc basi declin
report million oem revenu increas constant currenc basi report
million
sale geograph segment america sale increas constant currenc basi report
million driven intervent urolog vascular access revenu emea region increas
constant currenc basi declin report million due strength compani intervent
access vascular access product lastli asia revenu million increas constant currenc
basi report basi result growth surgic vascular access categori furthermor
within asia region china grew compani note strength korea southeast asia
pipelin updat importantli reiter plan domest launch urolift full convers
urolift similarli compani continu target launch urolift japan estim billion
full commerci furthermor compani would quantifi manta
revenu impact compani emphas posit feedback product follow limit market releas
oper period lastli follow on-going discuss fda receiv addit question
agenc regard repla call ez-plaz result compani longer plan file bla
submiss oper period compani comment new timelin bla submiss
earn call note model continu reflect contribut relat devic sale
balanc sheet review oper period gener million oper cash flow
result compani exit oper period million cash cash equival
billion debt result net debt posit billion accordingli tfx credit facil defin leverag ratio
stood approxim quarter end
dividend maintain conjunct compani oper result board director author
quarterli dividend per common share payabl septemb sharehold record close
busi august
million except per share data
good sold
sell gener administr
research develop
gm inc reas yoy result increas sale
volum on-going cost improv program
note million except per share data
compani document stephen inc estim
compani document stephen inc estim
compani document stephen inc
consolid statement incom non-gaap
million except per share data
fiscal period
fiscal period
fiscal period
good sold
sell gener administr
research develop
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
